gastric cancer/ esophageal cancer gastric cancer/ esophageal cancer
Conditions
Interventions
A small volume of the dilluted ICG solution was injected into submucosa using gastrointesitinal endoscopy
ICG, submucosal injection
Sponsors
Inaki Noriyuki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Patients who were diagnosed with gastric cancer or esophageal cancer(StageI-III) 2 Over 20 years old 3 Patients determined to be ready for general anesthesia and surgery 4 Performance Status (ECOG) 0 or 1 5 Objective procedure: Thoracoscopic esophagectomy, laparoscopic gastrectomy (including robot-assisted surgery) 6 Historical control: Patients who received surgery in Kanazawa University Hospital from January 2018 to October 2021(StageI-III) 7 Patients for whom informed consents were taken
Exclusion criteria
Exclusion criteria: 1 History of hypersensitivity to ICG 2 Hypersensitivity to iodine 3History of asthma or drug allergy 4 Judged to be difficult to participate in the study because of mental disorder 5 Inappropriate case determined by the principal invstigator/researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the number of lymph node dissections | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time, amount of blood loss, organ damage, adverse events | — |
Contacts
Public ContactToshikatsu Tsuji
Department of Gastrointestinal Surgery, Kanazawa University Hospital
Outcome results
None listed